Cargando…

Cardiovascular effects and tolerance of adenosine versus regadenoson during cardiac MRI perfusion testing

Detalles Bibliográficos
Autores principales:	Minor, Matthew, Lee, Joshua, Steel, Kevin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4328550/ http://dx.doi.org/10.1186/1532-429X-17-S1-P86

Ejemplares similares

Stress perfusion cardiac MRI with regadenoson and gadofoveset trisodium
por: Allen, Bradley D, et al.
Publicado: (2015)

Optimal timing of rest perfusion with regadenoson stress testing - normal volunteer study of quantitative MRI perfusion
por: Vasu, Sujethra, et al.
Publicado: (2011)

Effects of adenosine and regadenoson on hemodynamics measured using cardiovascular magnetic resonance imaging
por: Thomas, Dustin M., et al.
Publicado: (2017)

Regadenoson cardiovascular magnetic resonance myocardial perfusion imaging predicts need for future revascularization
por: Freed, Benjamin H, et al.
Publicado: (2012)

Regadenoson stress induced wall motion abnormalities during cardiac MRI
por: Parikh, Kalindi, et al.
Publicado: (2015)

Feasibility and results of acute cardiac stress MRI with regadenoson for risk stratification of COPD-patients with NSTEMI
por: Range, Felix T, et al.
Publicado: (2015)

Feasibility and preliminary diagnostic results of pixel-wise quantification of regadenoson first pass cardiac magnetic resonance perfusion imaging
por: Ta, Allison D, et al.
Publicado: (2014)

Feasibility of detecting myocardial ischemia using first-pass contrast MRI and regadenoson
por: Lyons, Matthew, et al.
Publicado: (2012)

Acute regadenoson stress prefusion testing using cardiac MRI is a valuable test of high predictive value for risk stratification of COPD-patients with NSTEM
por: Range, Felix T, et al.
Publicado: (2016)

Safety of adenosine stress perfusion cardiac MRI in patients undergoing lung transplantation evaluation
por: Chang, Sung A, et al.
Publicado: (2016)

Risk stratification by regadenoson stress MRI in patients with known or suspected coronary artery disease
por: Abbasi, Siddique A, et al.
Publicado: (2014)

Is cardiac MRI adenosine stress perfusion imaging a more appropriate diagnostic tool for obese patients?
por: Mikolich, Ronald J, et al.
Publicado: (2012)

Safety and Efficacy of Regadenoson for Pediatric Stress Perfusion Cardiac MRI with Quantification of Myocardial Blood Flow
por: Patel, Shivani G., et al.
Publicado: (2022)

Determinants of myocardial perfusion reserve measured from coronary sinus phase-contrast imaging during regadenoson stress CMR
por: Bauml, Michael A, et al.
Publicado: (2014)

Subendocardial reversible perfusion defects on adenosine stress MRI in ER patients with chest pain: relationship to cardiovascular risk factors
por: Skrok, Jan, et al.
Publicado: (2009)

Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease
por: Kero, Tanja, et al.
Publicado: (2021)

Feasibility and safety of high-dose adenosine perfusion cardiovascular magnetic resonance imaging
por: Karamitsos, Theodoros D, et al.
Publicado: (2011)

Prognostic value of adenosine stress perfusion cardiac magnetic resonance with late gadolinium enhancement
por: Bertaso, Angela G, et al.
Publicado: (2011)

Stress perfusion cardiac MRI in women
por: h-Ici, Darach O, et al.
Publicado: (2011)

Effects of caffeine intake prior to stress cardiac magnetic resonance perfusion imaging on regadenoson- versus adenosine-induced hyperemia as measured by T1 mapping
por: van Dijk, R., et al.
Publicado: (2017)

Prognostic value of normal regadenoson stress perfusion cardiovascular magnetic resonance
por: Freed, Benjamin H, et al.
Publicado: (2013)

Initial results of a new very rapid rest/regadenoson stress myocardial perfusion protocol in patients with atrial fibrillation
por: Chang, Lowell, et al.
Publicado: (2014)

MRI adenosine fist-pass perfusion analysis using a SSFP sequence – are there gender differences?
por: Merkle, Nico, et al.
Publicado: (2009)

Diagnostic performance of regadenoson stress CMR for detection of coronary artery disease
por: Patel, Mita, et al.
Publicado: (2015)

LV wall motion assessment during regadenoson vasodilator stress CMR
por: Jesinger, Michael, et al.
Publicado: (2016)

Editorial: Regadenoson: An adenosine A(2A) receptor agonist for pharmacological myocardial perfusion imaging
por: Matsuo, Shinro
Publicado: (2014)

Regadenoson as a pharmacologic stressor in cardiac magnetic resonance imaging in congenital and acquired pediatric heart disease: initial experience
por: Noel, Cory V, et al.
Publicado: (2015)

Regadenoson and adenosine are equivalent vasodilators and are superior than dipyridamole- a study of first pass quantitative perfusion cardiovascular magnetic resonance
por: Vasu, Sujethra, et al.
Publicado: (2013)

Initial description of changes in wall motion parameters in normal subjects undergoing rest/regadenoson stress using a tagged MRI sequence
por: Soltys, Joseph S, et al.
Publicado: (2016)

Incremental value of cardiac magnetic resonance with adenosine stress perfusion in coronary artery disease detection
por: Pereira, Eulalia, et al.
Publicado: (2013)

Adenosine stress perfusion CMR accurately identifies the culprit vessel
por: Richardson, James D, et al.
Publicado: (2011)

Safety and tolerability of regadenoson CMR
por: Nguyen, Kim-Lien, et al.
Publicado: (2014)

Impaired coronary vasodilation with Regadenoson in patients with angiographically normal coronaries when compared to normal volunteers - Insights from Quantitative MRI Perfusion
por: Vasu, Sujethra, et al.
Publicado: (2011)

Clinical evaluation of inline motion correction for cardiac perfusion MRI
por: Kino, Aya, et al.
Publicado: (2011)

Integrated quantitative first-pass cardiac perfusion MRI protocol
por: Breton, Elodie, et al.
Publicado: (2011)

Quantification of perfusion defects with high resolution 2D and 3D adenosine stress perfusion 3.0 Tesla CMR
por: McDiarmid, Adam K, et al.
Publicado: (2014)

Lipid sub-fractionation predicts worsening myocardial perfusion reserve in patients with low-density lipoprotein less than 100mg/dL: a regadenoson dardiac magnetic resonance study
por: Narang, Akhil, et al.
Publicado: (2012)

Regadenoson is a better myocardial vasodilator than dipyridamole in normal volunteers, but the data is less compelling in patients
por: Vasu, Sujethra, et al.
Publicado: (2011)

Adenosine cardiac magnetic resonance: follow-up of patients with very high cardiovascular risk
por: Esteban-Fernández, Alberto, et al.
Publicado: (2015)

Seizure: An Adverse Effect of Regadenoson in Myocardial Perfusion Imaging
por: Radwan, Sohab S., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bgfkveqb77usl70fe4vn8tgpen